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Telemedicine Abortion in the United States
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(COVID-19) Pandemic
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James G. Scott, PhD, and Catherine E. Aiken, MB BChir, PhD
INTRODUCTION
For many in the United States, abortion care is
already difficult to access,1 and the coronavirus dis-
ease 2019 (COVID-19) pandemic has created yet
more potential barriers—including infection risk at
clinics and state policies limiting in-clinic services.
The severity of these state policies varies, but, in the
most extreme case, Texas effectively suspended all
abortions for approximately 4 weeks.2 As a result,
people may increasingly be seeking self-managed
abortion outside the formal health care system.
Using data from Aid Access, the sole online abortion
telemedicine service in the United States, we assessed
whether demand for self-managed medication abor-
tion increased as in-clinic access became more
challenging.
METHODS
Aid Access provides medication abortion up to 10
weeks of gestation for those who make a request using
an online consultation form.3 We analyzed fully de-
identified data provided by the service on all 49,935
requests received between January 1, 2019, and April
11, 2020, when the service temporarily paused.
We used regression discontinuity to compare requests
from each state before and after the state implemented
a business-closure order to slow virus transmission.4
We also compiled information on the scope and im-
plementation date of any state-level COVID-19–
related abortion restrictions.2 We assessed the signifi-
cance of each state’s discontinuity using a likelihood-
ratio test compared with a null model without a discon-
tinuity, and we calculated the percentage difference
between actual requests and expected requests under
the null model in the “after” period. For each state, we
examined the prevalence of COVID-19 on the day of
the business-closure order.5 We also examined median
daily time spent at home by residents in each state
using data from aggregated, anonymized mobile device
GPS traces provided by SafeGraph.6 See Appendices
1–6, available online at http://links.lww.com/AOG/
C18, for details of all analyses. The University of Texas
at Austin Institutional Review Board approved the
study.
RESULTS
From March 20, 2020, to April 11, 2020 (the average
“after” period across all states), there was a 27%
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increase in the rate of requests for self-managed med-
ication abortion across the United States (P,.001)
(Table 1).
Eleven states showed individually significant increases
in requests, ranging from 22% in Ohio (P5.012) to
94% in Texas (P,.001) (Table 1). Median time spent
at home was 5% higher for these states compared with
states without significant changes in requests (P5.037)
(Appendix 6, http://links.lww.com/AOG/C18).
States with significant increases in requests either
Table 1. Actual Compared With Expected Numbers of Requests for Self-Managed Medication Abortion in
the “After” Period for the United States Overall and for Each State Included in the Study
Change in Aid
Access Requests State
Actual
Requests*
Expected
Requests
Percent Change
Over Baseline Trend† 95% CI
All states‡ 3,343 2,638.2 26.7 22.7 to 32.2
Significant increase Texas 787 406.4 93.6 76.5 to 113.3
Massachusetts 37 22.4 64.9 15.6 to 164.3
New York 157 97.9 60.4 33.1 to 98.7
Louisiana 135 85.3 58.3 28.6 to 101.5
Washington 52 38.5 34.9 2.0 to 92.6
California 219 169.2 29.4 11.7 to 51.0
New Jersey 77 59.6 29.1 2.7 to 71.1
Illinois 75 58.7 27.7 1.4 to 70.5
Oklahoma 39 31.0 25.7 7.1 to 85.7
Tennessee 83 66.7 24.4 1.0 to 62.7
Ohio 173 142.0 21.8 4.2 to 45.4
Significant decrease Kentucky 39 55.9 230.2 245.1 to 27.1
Changes of at least
20%, but not significant
Kansas 22 16.7 32.0 212.0 to 144.4
New Mexico 15 11.4 31.3 221.1 to 120.0
Oregon 20 16.7 20.1 220.0 to 122.2
Utah 8 11.3 228.9 223.1 to 100.0
Changes of less than
20% and not significant
Minnesota 20 17.6 13.8 214.0 to 53.1
Maryland 49 43.9 11.6 26.8 to 36.3
Virginia 124 111.7 11.0 218.4 to 60.0
Arizona 40 36.1 10.9 213.0 to 42.6
South Carolina 67 61.4 9.0 220.5 to 59.1
Mississippi 35 32.6 7.4 218.9 to 53.6
Colorado 43 40.1 7.1 212.3 to 34.8
Georgia 93 87.2 6.7 228.6 to 81.8
West Virginia 20 19.2 4.2 226.3 to 64.7
Iowa 28 27.1 3.3 215.2 to 29.2
Indiana 84 81.5 3.1 29.2 to 18.3
Florida 226 219.5 3 234.6 to 70.0
Missouri 17 17.0 0 218.3 to 21.2
Pennsylvania 103 105.4 22.3 240.0 to 10.0
Connecticut 12 12.5 23.7 221.1 to 15.5
North Carolina 97 102.8 25.6 232.6 to 34.8
Nevada 31 33.5 27.4 226.7 to 16.7
Michigan 63 69.0 28.7 231.5 to 27.6
Wisconsin 37 41.4 210.7 233.3 to 25.9
Arizona 34 38.3 211.1 233.7 to 10.0
Alabama 55 65.8 216.4 255.6 to 60.0
* Actual requests are cumulative counts for the period from initial business-closure order to April 11, 2020. Expected requests were
obtained as forecasts from the null model for each state, which assumes no discontinuities.
† Percent increases are percentages, calculated as 1003(actual2expected)/expected. P-values were obtained from a likelihood ratio test of
the regression-discontinuity model vs the null model of no discontinuity. Low P-values indicate evidence for the presence of a
discontinuity (ie, that the percent increase over baseline is statistically significant).
‡ Thirteen states and Washington, DC, were omitted owing to fewer than 10 expected postrestriction requests: Alaska, Delaware, Hawaii,
Idaho, Maine, Montana, North Dakota, Nebraska, New Hampshire, Rhode Island, South Dakota, Vermont, Wyoming.
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had particularly high COVID-19 rates or more severe
COVID-19–related restrictions on in-clinic abortion
access (Appendix 5, http://links.lww.com/AOG/C18).
DISCUSSION
Our results may reflect two distinct phenomena.
First, more people may be seeking abortion
through all channels, whether due to COVID-19
risks during pregnancy, reduced access to prenatal
care, or the pandemic-related economic down-
turn.7,8 Second, there may be shift in demand from
in-clinic to self-managed abortion during the pan-
demic, possibly owing to fear of infection during in-
person care or inability to get to a clinic because of
childcare and transit disruptions. In support of
these possibilities, we observed higher levels of
stay-at-home behavior in states with significant
increases in requests.
Among states that limited access to in-clinic abortion
during the pandemic, we observed larger increases in
requests in states with the most severe and longest-
lasting restrictions. Texas, the state with the most
restrictive measures, showed the largest increase in
requests, despite a relatively low burden of COVID-
19 during the study timeframe.
In terms of limitations, we could not measure all
pathways to self-managed abortion in the United
States, and we may have lacked power to detect
changes in some states with low request numbers or
where abortion restrictions were implemented toward
the end of the study.
The World Health Organization recommends tele-
medicine and self-management abortion-care models
during the pandemic, and the United Kingdom has
temporarily implemented fully remote provision of
abortion medications.9,10 In the United States, such
services would depend on sustained changes to the
U.S. Food and Drug Administration’s Risk Evaluation
and Mitigation Strategy, which requires patients to
collect mifepristone at a hospital or medical facility,
as well as changes to state-specific laws that prohibit
remote provider consultation.11 Our findings suggest
that telemedicine models for medication abortion
should be a policy priority; when in-clinic abortion
services are not accessible, people may seek alterna-
tive ways of accessing time-sensitive care.
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